Wockhardt Ltd
Gajanand Sahu is an accomplished finance professional with extensive experience in group finance, company secretarial, and compliance roles across various industries, including telecom, service, and manufacturing. Currently serving as the Group Finance Controller and Ex-Company Secretary & Compliance Officer at Wockhardt Ltd. since September 2019, Gajanand oversees the finalization of financial results for the entire group and manages accounting alignment for 32 companies outside India and 60 Indian companies. Prior experience includes a General Manager role at Vodafone Idea Limited, where responsibilities encompassed financial statement preparation, IPO coordination, and merger and acquisition accounting. Additional roles include serving as AVP and Company Secretary at BA Continuum India, Manager Finance at Sudarshan Chemical Industries, and Manager MIS at UPL Limited. Gajanand holds multiple professional qualifications, including Chartered Accountant, Company Secretary, and a degree in Commercial Laws, complemented by advanced education in management accounting and legal studies.
This person is not in any offices
Wockhardt Ltd
1 followers
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.